New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
06:33 EDTJNJAdult migraine medicines found ineffective in children, Bloomberg reports
About 8M children, or 1 of 20 in the U.S., get migraines, research shows, but medicines to prevent or treat migraines in adults aren’t effective in stopping the headaches in children, according to two studies, reports Bloomberg. An analysis of 21 trials published in JAMA Pediatrics showed that Johnson and Johnson’s (JNJ) seizure medicine Topamax and the antidepressant trazodone “have limited evidence” to support use in children’s migraines occurring fewer than 15 times a month. Other drugs, including some medicines for hypertension are no better than a placebo, the research found. Reference Link
News For JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
08:12 EDTJNJJ&J granted orphan status for acute myeloid leukemia treatment
The FDA granted Johnson & Johnson unit Janssen Research orphan status for its acute myeloid leukemia treatment.
May 4, 2015
07:35 EDTJNJNewYorkBio to hold a conference
Subscribe for More Information
May 3, 2015
18:11 EDTJNJSiemens investigated by Chinese regulator last year, Reuters says
Subscribe for More Information
May 1, 2015
16:49 EDTJNJJ&J says Costco filed complaint against Vision Care unit
Subscribe for More Information
07:43 EDTJNJExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 29, 2015
17:00 EDTJNJJohnson & Johnson announces further patent action related to Remicade
Subscribe for More Information
12:25 EDTJNJPerrigo rumored to possibly draw interest beyond Mylan bid, Bloomberg says
Subscribe for More Information
April 27, 2015
06:19 EDTJNJPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 23, 2015
14:20 EDTJNJEarnings Watch: Google up close to 8.5% since last earnings report
Subscribe for More Information
11:02 EDTJNJJohnson & Johnson increases dividend by 7.1% to 75c
Subscribe for More Information
10:02 EDTJNJAbbVie says communication with Johnson & Johnson has been 'very positive'
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use